Lupin’s arm achieves NABL accreditation across all greenfield labs

23 Apr 2025 Evaluate

Lupin’s wholly owned subsidiary -- Lupin Diagnostics (LDL) has achieved 100% National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation across all its greenfield labs.  This notable achievement highlights the adherence to rigorous quality control measures, reinforcing LDL’s unwavering dedication to providing top-tier diagnostic services. The company’s commitment to quality is reflected in every aspect of its operations, ensuring patients receive accurate and timely results that they can trust. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2323.60 -33.25 (-1.41%)
13-Mar-2026 12:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.05
Dr. Reddys Lab 1286.20
Cipla 1305.40
Zydus Lifesciences 903.15
Lupin 2323.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×